The estimated Net Worth of Christopher H Wright is at least 265 千$ dollars as of 28 November 2018. Christopher Wright owns over 10,000 units of Misonix Inc stock worth over 265,400$ and over the last 9 years Christopher sold MSON stock worth over 0$.
Christopher has made over 1 trades of the Misonix Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Christopher exercised 10,000 units of MSON stock worth 76,700$ on 28 November 2018.
The largest trade Christopher's ever made was exercising 10,000 units of Misonix Inc stock on 28 November 2018 worth over 76,700$. On average, Christopher trades about 1,429 units every 0 days since 2015. As of 28 November 2018 Christopher still owns at least 10,000 units of Misonix Inc stock.
You can see the complete history of Christopher Wright stock trades at the bottom of the page.
Christopher's mailing address filed with the SEC is 1938 New Hwy, Farmingdale, NY 11735, USA.
Over the last 21 years, insiders at Misonix Inc have traded over 4,371,211$ worth of Misonix Inc stock and bought 1,536,334 units worth 6,620,934$ . The most active insiders traders include Stavros G. Vizirgianakis、Gary Gelman、Michael A Jr Mcmanus. On average, Misonix Inc executives and independent directors trade stock every 29 days with the average trade being worth of 378,885$. The most recent stock trade was executed by Sharon W Klugewicz on 20 May 2020, trading 825 units of MSON stock currently worth 10,032$.
Misonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company's history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients.
Misonix Inc executives and other stock owners filed with the SEC include: